426 related articles for article (PubMed ID: 9519740)
1. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
Pick A; Clark J; Kubstrup C; Levisetti M; Pugh W; Bonner-Weir S; Polonsky KS
Diabetes; 1998 Mar; 47(3):358-64. PubMed ID: 9519740
[TBL] [Abstract][Full Text] [Related]
2. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes.
Cockburn BN; Ostrega DM; Sturis J; Kubstrup C; Polonsky KS; Bell GI
Diabetes; 1997 Sep; 46(9):1434-9. PubMed ID: 9287043
[TBL] [Abstract][Full Text] [Related]
3. Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
Zhou YP; Cockburn BN; Pugh W; Polonsky KS
Metabolism; 1999 Jul; 48(7):857-64. PubMed ID: 10421226
[TBL] [Abstract][Full Text] [Related]
4. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.
Sreenan SK; Mittal AA; Dralyuk F; Pugh WL; Polonsky KS; Roe MW
Metabolism; 2000 Dec; 49(12):1579-87. PubMed ID: 11145120
[TBL] [Abstract][Full Text] [Related]
6. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
7. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
Delghingaro-Augusto V; Décary S; Peyot ML; Latour MG; Lamontagne J; Paradis-Isler N; Lacharité-Lemieux M; Akakpo H; Birot O; Nolan CJ; Prentki M; Bergeron R
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E254-64. PubMed ID: 22045312
[TBL] [Abstract][Full Text] [Related]
8. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.
Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M
Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750
[TBL] [Abstract][Full Text] [Related]
9. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat.
Sturis J; Pugh WL; Tang J; Ostrega DM; Polonsky JS; Polonsky KS
Am J Physiol; 1994 Aug; 267(2 Pt 1):E250-9. PubMed ID: 8074204
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.
Smith SA; Lister CA; Toseland CD; Buckingham RE
Diabetes Obes Metab; 2000 Dec; 2(6):363-72. PubMed ID: 11225966
[TBL] [Abstract][Full Text] [Related]
11. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
[TBL] [Abstract][Full Text] [Related]
12. Low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of Zucker diabetic fatty rats.
MacDonald MJ; Tang J; Polonsky KS
Diabetes; 1996 Nov; 45(11):1626-30. PubMed ID: 8866570
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats.
Wu L; Yang W; Jia X; Yang G; Duridanova D; Cao K; Wang R
Lab Invest; 2009 Jan; 89(1):59-67. PubMed ID: 19002107
[TBL] [Abstract][Full Text] [Related]
14. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.
Jones HB; Nugent D; Jenkins R
Int J Exp Pathol; 2010 Jun; 91(3):288-301. PubMed ID: 20384904
[TBL] [Abstract][Full Text] [Related]
15. Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats.
Janssen SW; Hermus AR; Lange WP; Knijnenburg Q; van der Laak JA; Sweep CG; Martens GJ; Verhofstad AA
Exp Clin Endocrinol Diabetes; 2001; 109(5):273-82. PubMed ID: 11507651
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic peptides in young and elderly Zucker type 2 diabetic fatty rats.
Howarth FC; Al Kitbi MK; Hameed RS; Adeghate E
JOP; 2011 Nov; 12(6):567-73. PubMed ID: 22072245
[TBL] [Abstract][Full Text] [Related]
17. Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function.
Paulsen SJ; Vrang N; Larsen LK; Larsen PJ; Jelsing J
J Anat; 2010 Nov; 217(5):624-30. PubMed ID: 20807269
[TBL] [Abstract][Full Text] [Related]
18. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
19. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes.
Hirose H; Lee YH; Inman LR; Nagasawa Y; Johnson JH; Unger RH
J Biol Chem; 1996 Mar; 271(10):5633-7. PubMed ID: 8621426
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of compensatory beta-cell growth in insulin-resistant rats: roles of Akt kinase.
Jetton TL; Lausier J; LaRock K; Trotman WE; Larmie B; Habibovic A; Peshavaria M; Leahy JL
Diabetes; 2005 Aug; 54(8):2294-304. PubMed ID: 16046294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
